Eli Lilly and Company Total Debt 2008–2025
Eli Lilly and Company reported $42.50B of total debt (short- plus long-term borrowings) for fiscal 2025. That was 22.9% higher than fiscal 2024. Compared with fiscal 2020, the change was +159.8%.
| Fiscal year | Total Debt | Change (YoY) |
|---|---|---|
| FY 2025 | $42.50B | +22.9% |
| FY 2024 | $34.59B | +33.0% |
| FY 2023 | $26.01B | +59.4% |
| FY 2022 | $16.32B | -10.7% |
| FY 2021 | $18.28B | +11.8% |
| FY 2020 | $16.36B | +8.1% |
| FY 2019 | $15.14B | +47.0% |
| FY 2018 | $10.30B | -24.5% |
| FY 2017 | $13.65B | +24.7% |
| FY 2016 | $10.94B | +37.1% |
| FY 2015 | $7.98B | -0.5% |
| FY 2014 | $8.02B | +28.8% |
| FY 2013 | $6.23B | +12.3% |
| FY 2012 | $5.54B | -34.8% |
| FY 2011 | $8.50B | +22.5% |
| FY 2010 | $6.94B | +3.9% |
| FY 2009 | $6.68B | -36.1% |
| FY 2008 | $10.46B | — |
Source: Eli Lilly and Company SEC filings — balance sheet (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open LLY 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Eli Lilly and Company reported $42.50B of total debt (short- plus long-term borrowings) for fiscal 2025. That was 22.9% higher than fiscal 2024. Compared with fiscal 2020, the change was +159.8%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Eli Lilly and Company
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeEli Lilly and Company — frequently asked questions
What is Eli Lilly and Company's total debt (short- plus long-term borrowings)?
Eli Lilly and Company (LLY) reported total debt (short- plus long-term borrowings) of $42.50B for fiscal year 2025, per its SEC filings.
How has Eli Lilly and Company's total debt (short- plus long-term borrowings) changed over time?
Between fiscal 2008 and 2025, LLY's total debt (short- plus long-term borrowings) grew at roughly 8.6% per year (compound annual rate), from $10.46B to $42.50B.
Where does this data come from?
Figures are computed from Eli Lilly and Company's official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.
More LLY financial history
Full LLY fundamentals page → · Analyze total debt (short- plus long-term borrowings) with a free tool → · All 1,500+ companies →